COVID-19
|
SUBSCRIBE
|
FAQs
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
PRESENTATIONS
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
SAHPRA TV
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
GUIDELINES
POSITION STATEMENTS
COMMUNICATION TO INDUSTRY
TEST KITS
RELATED DOCUMENTS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
NEW AUTHORIZATIONS
RE-AUTHORIZATIONS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
HOME
ABOUT US
WHO WE ARE
THE SAHPRA BOARD
EXECUTIVE MANAGEMENT
REGULATORY PARTNERSHIP
SPECIAL PROJECTS
BACKLOG
VACANCIES
NEWS
LATEST NEWS & UPDATES
PRESS RELEASES
PRESENTATIONS
SAFETY ALERTS
UPCOMING EVENTS
WORKSHOPS AND CONFERENCES
SAHPRA TV
HEALTH PRODUCTS
ORTHODOX MEDICINES
GUIDELNES
TEMPLATES
BIOLOGICAL PRODUCTS
GUIDELINES
COMPLEMENTARY MEDICINES
APPLICATION FORMS
COMMUNICATION TO INDUSTRY
GUIDELINES
TEMPLATES
MEDICAL DEVICES
APPLICATION FORMS
GUIDELINES
POSITION STATEMENTS
COMMUNICATION TO INDUSTRY
TEST KITS
RELATED DOCUMENTS
RADIATION CONTROL
ACTS AND REGULATIONS
APPLICATION AND REPORT FORMS
GUIDELNES AND CODES OF PRACTICE
UNREGISTERED PRODUCTS
GUIDELINES
VETERINARY MEDICINES
GUIDELNES
E-SERVICES
ACCESS TO UNREGISTERED HEALTH PODUCTS
NEW AUTHORIZATIONS
RE-AUTHORIZATIONS
ADVERSE DRUG REACTION REPORTING
COMPLEMENTARY MEDICINES LICENSING
COVI-VIG REPORTING SYSTEM
HEALTH PRODUCT APPLICATION STATUS CHECKER
PRODUCT VARIATIONS PORTAL
PUBLICATIONS
ACTS AND REGULATIONS
ANNUAL REPORT
CORPORATE IDENTITY
GOVERNMENT GAZETTES AND REGULATIONS
GUIDELINES
FEES
PRESENTATIONS
SAHPRA PLANNING DOCUMENTS
TENDERS
CONTACT US
HEAD OFFICE
KEY CONTACTS
MEDIA ENQUIRIES
FEEDBACK AND COMPLAINTS
Covid-19 Tag
Press Releases
Update: SAHPRA and the SputnikV Vaccine
February 24, 2021
Press Releases
SAHPRA and Rollout to President and Deputy President
February 18, 2021
News & Updates
Press Releases
SAHPRA clarifies its stance on Ivermectin
February 3, 2021
Press Releases
Update on the use of ivermectin in the prevention or treatment of COVID-19
January 28, 2021
News & Updates
Press Releases
SAHPRA AUTHORISES COVISHIELD – AN ADENOVIRUS-VECTORED VACCINE FOR THE PREVENTION OF COVID-19
January 27, 2021
News & Updates
Extension of Post Importation Testing Exemptions
December 22, 2020
News & Updates
Frequently Asked Questions: New Variant of SARS-CoV-2 in South Africa
December 19, 2020
Press Releases
SAHPRA will commence review of vaccine applications for registration for COVID-19
December 15, 2020
News & Updates
INFORMATION AND GUIDANCE ON IMMUNIZATION WITH THE NEW COVID-19 VACCINES
December 10, 2020
News & Updates
INFORMATION AND GUIDANCE ON APPLICATION FOR REGISTRATION OF CANDIDATE COVID-19 VACCINE
December 4, 2020
1
2
